0001562180-23-006222.txt : 20230807 0001562180-23-006222.hdr.sgml : 20230807 20230807160713 ACCESSION NUMBER: 0001562180-23-006222 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230803 FILED AS OF DATE: 20230807 DATE AS OF CHANGE: 20230807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leschly Nick CENTRAL INDEX KEY: 0001578408 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40791 FILM NUMBER: 231147642 MAIL ADDRESS: STREET 1: C/O BLUEBIRD BIO, INC. STREET 2: 840 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 2seventy bio, Inc. CENTRAL INDEX KEY: 0001860782 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 863658454 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02210 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02210 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2023-08-03 false 0001860782 2seventy bio, Inc. TSVT 0001578408 Leschly Nick 60 BINNEY STREET CAMBRIDGE MA 02142 true true false false President and CEO true Common Stock 2023-08-03 4 S false 9060.00 6.1257 D 1168654.00 D Common Stock 15233.00 I Nick Leschly 2001 Trust Common Stock 41000.00 I Nick Leschly Irrevocable GST Trust of 2019 Shares were sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.06 to $6.23, inclusive. The Reporting Person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The Form 4 filed on July 19, 2022 inadvertently understated the Reporting Person's holdings by 133,500 shares, an error that was carried forward on subsequent filings. Column 5 of Table I reflects the number of shares of Issuer common stock beneficially owned by the Reporting Person following the reported transactions as of August 7, 2023. /s/ Teresa Jurgensen, Attorney-in-Fact 2023-08-07